MARKETSHorizon Pharma Stock Goes Vertical After Positive Eye Disease Drug ResultsBy Scott Van VoorhisFeb 28, 2019 11:10 AM EST
PRESS RELEASESFDA Approves TEPEZZATM (teprotumumab-trbw) For The Treatment Of Thyroid Eye Disease (TED)By Business WireJan 21, 2020 3:04 PM EST
PRESS RELEASESHorizon Therapeutics Plc Increases Peak U.S. Annual Net Sales Expectations For Key Growth Drivers; Provides Update On Several Pipeline ProgramsBy Business WireJan 13, 2020 8:15 AM EST
PRESS RELEASESMIRROR Open-Label Study Topline Data Of Methotrexate With KRYSTEXXA (pegloticase Injection) Indicates Significant Improvement In Response RateBy Business WireJan 13, 2020 8:05 AM EST
MARKETSHorizon Pharma Stock Goes Vertical After Positive Eye Disease Drug ResultsBy Scott Van VoorhisFeb 28, 2019 11:10 AM EST
JIM CRAMERPepsiCo, Ford Motor, Teladoc: 'Mad Money' Lightning RoundBy Scott RuttJan 30, 2019 8:11 PM EST
REGULATIONWhy investors shouldn't worry about Trump's tough talk on drug pricesBy Bill MeagherFeb 8, 2018 9:09 AM EST
FUTURESDow Scores Ninth Straight Record Close With Tiny GainsBy Keris Alison LahiffAug 7, 2017 8:10 PM EDT
FUTURESDow Is Back on Track to Close at a Record High as Consumer Staples LeadBy Keris Alison LahiffAug 7, 2017 3:10 PM EDT
FUTURESEnergy Losses Put Dow's Record-Breaking Streak in JeopardyBy Keris Alison LahiffAug 7, 2017 10:41 AM EDT
HEALTHBiotech Movers: Second Quarter Results, Increased Outlook Send Horizon Pharma Shares HigherBy Armie Margaret LeeAug 7, 2017 9:27 AM EDT
FUTURESStock Futures Rise as Dow Shoots for Its Ninth Straight Day of RecordsBy Keris Alison LahiffAug 7, 2017 8:39 AM EDT
VIDEOClosing Bell: Volatility at Lowest Since 1993; Pershing Backs Howard HughesBy Keris Alison LahiffMay 8, 2017 4:37 PM EDT
FUTURESStocks Tread Water as Volatility Reaches Lowest Level in 24 YearsBy Keris Alison LahiffMay 8, 2017 4:07 PM EDT
FUTURESStocks Lower Again in 'Comfortably Numb' Trading, Volatility at 24-Year LowBy Keris Alison LahiffMay 8, 2017 2:57 PM EDT
FUTURESStocks Creep Lower in 'Comfortably Numb' Trading After French ElectionBy Keris Alison LahiffMay 8, 2017 11:20 AM EDT
FUTURESStock Futures Dip After Macron Win in French ElectionBy Keris Alison LahiffMay 8, 2017 8:32 AM EDT
JIM CRAMERChicago Bridge and Iron, Mobileye, Horizon Pharmaceuticals: 'Mad Money' Lightning RoundBy Scott RuttMar 4, 2017 6:17 AM EST
JIM CRAMERJobs Data, Earnings Back in the Spotlight for Next Week: Cramer's 'Mad Money' RecapBy Scott RuttMar 3, 2017 8:13 PM EST
STOCKS9 Allergan drugs may now cost as much as 9.5% more in 2017By Sarah PringleJan 7, 2017 3:03 PM EST
